Blog

Transforming melanoma treatment in Manchester – Manchester Cancer Research Centre

Manchester Cancer Research Centre/mcrc.manchester.ac.uk

Apr 16, 2025, 07:43

Transforming melanoma treatment in Manchester – Manchester Cancer Research Centre

Manchester Cancer Research Centre shared a post on LinkedIn:

“Transforming melanoma treatment in Manchester.

Melanoma is the 5th most common cancer in the UK, but researchers in Manchester are transforming our understanding and treatment of the disease.

The CAcTUS clinical trial at The Christie NHS Foundation Trust is investigating how circulating tumour DNA (ctDNA) can be used to personalise treatment options for patients with advanced melanoma. By identifying the best time to switch between targeted therapy and immunotherapy, the trial hopes to improve patient outcomes and help optimise treatment strategies.

Learn more about the future of melanoma research in Manchester.

Click here to watch the video.”

CAcTUS clinical trial cancer circulating tumour DNA ctDNA fight against cancer Global fight against cancer immunotherapy Manchester Manchester Cancer Research Centre Melanoma OncoDaily Oncology targeted therapy The Christie NHS Foundation Trust

USA vs Europe: Who Does Cancer Screening Better?

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Penn Medicine: Cancer Center Near Me

Elevating Childhood Cancer and Catastrophic Diseases in the Global NCD Agenda: Joint Call to Action